Overview

Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
This study will test the effects of valsartan versus placebo on exercise tolerance in patients with symptoms of heart failure
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Valsartan